Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Cash & Equivalents (2009 - 2026)

Updated

Bristol Myers Squibb's Cash & Equivalents came in at $9.57 billion for Q3 2026, down 39.1% from $15.73 billion a year earlier but up 9.8% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Cash & Equivalents (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb's Cash & Equivalents was $10.21 billion, down 1.3% from FY2024.

  • Cash & Equivalents carries a five-year compound annual growth rate of -6.8% (FY2020 to FY2025).
  • Going back by year, Cash & Equivalents was $10.35 billion in FY2024 (-9.8%), $11.46 billion in FY2023 (+25.7%), $9.12 billion in FY2022 (-34.7%) and $13.98 billion in FY2021 (-3.9%).
  • The five-year range for quarterly Cash & Equivalents is $6.29 billion (Q2 2024) to $15.73 billion (Q3 2025).
  • Year-over-year, Cash & Equivalents has declined for four consecutive quarters, with growth averaging 15.4% over the last eight quarters.
  • The fastest year-over-year change in Cash & Equivalents over five years came in Q2 2025 (growth of 100.2%), and the weakest in Q3 2022 (a decline of 42.9%).
  • Business Quant data shows BMY's Cash & Equivalents at $8.72 billion (Q2 2026), $9.57 billion (Q1 2026) and $10.21 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 16.91 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 10.77 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 9.55 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 400.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 7.94 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 1.82 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 9.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.57 Bn
Jun 30, 2026 8.72 Bn
Mar 31, 2026 9.57 Bn
Dec 31, 2025 10.21 Bn
Sep 30, 2025 15.73 Bn
Jun 30, 2025 12.60 Bn
Mar 31, 2025 10.88 Bn
Dec 31, 2024 10.35 Bn
Sep 30, 2024 7.89 Bn
Jun 30, 2024 6.29 Bn
Mar 31, 2024 9.33 Bn
Dec 31, 2023 11.46 Bn
Sep 30, 2023 7.51 Bn
Jun 30, 2023 8.37 Bn
Mar 31, 2023 9.00 Bn
Dec 31, 2022 9.12 Bn
Sep 30, 2022 7.73 Bn
Jun 30, 2022 10.75 Bn
Mar 31, 2022 12.37 Bn
Dec 31, 2021 13.98 Bn
API Access

Bristol Myers Squibb Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BMY&period=max&api_key=YOUR_API_KEY